483 Changzhou Tianhua Pharmaceutical Jan 2017

483 Changzhou Tianhua Pharmaceutical Jan 2017

Yasamin Ameri FDA, Roger Zabinski FDA$119.00 - Available Now

FDA investigators audited the Changzhou Tianhua Pharmaceutical - Jintan, China facility and issued inspectional observations (via FDA 483) on 13 Jan 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Jan 2017
  • Location: Jintan, China
  • FEI: 3003895439
Add To Cart